Display options
Share it on

Immune Netw. 2009 Aug;9(4):115-21. doi: 10.4110/in.2009.9.4.115. Epub 2009 Aug 31.

Post-transcriptional Regulation of NK Cell Activation.

Immune network

Tae-Don Kim, Ju Yeong Park, Inpyo Choi

Affiliations

  1. Cell Therapy Research Center, Korea Research Institute of Bioscience and Biotechnology, University of Science and Technology, Daejeon 305-806, Korea.

PMID: 20157597 PMCID: PMC2816943 DOI: 10.4110/in.2009.9.4.115

Abstract

Natural killer (NK) cells play key roles in innate and adaptive immune defenses. NK cell responses are mediated by two major mechanisms: the direct cytolysis of target cells, and immune regulation by production of various cytokines. Many previous reports show that the complex NK cell activation process requires de novo gene expression regulated at both transcriptional and post-transcriptional levels. Specialized un-translated regions (UTR) of mRNAs are the main mechanisms of post-transcriptional regulation. Analysis of post-transcriptional regulation is needed to clearly understand NK cell biology and, furthermore, harness the power of NK cells for therapeutic aims. This review summarizes the current understanding of mRNA metabolism during NK cell activation, focusing primarily on post-transcriptional regulation.

Keywords: cytotoxicity; immune regulation; natural killer cells; post-transcriptional regulation

References

  1. EMBO J. 1998 Jun 15;17(12):3448-60 - PubMed
  2. Biochem Biophys Res Commun. 2002 Mar 22;292(1):184-9 - PubMed
  3. Immunity. 2007 Jun;26(6):798-811 - PubMed
  4. Annu Rev Immunol. 2008;26:389-420 - PubMed
  5. Genes Dev. 2005 Feb 1;19(3):351-61 - PubMed
  6. Mol Cell Biochem. 2005 Mar;271(1-2):13-22 - PubMed
  7. Am J Respir Cell Mol Biol. 2008 Sep;39(3):364-72 - PubMed
  8. Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5761-6 - PubMed
  9. J Mol Biol. 1992 Aug 5;226(3):721-33 - PubMed
  10. J Immunol. 2009 May 15;182(10):6287-97 - PubMed
  11. Mol Cell Biol. 2002 Mar;22(6):1742-53 - PubMed
  12. Nat Immunol. 2008 Sep;9(9):1065-73 - PubMed
  13. Eur J Biochem. 2003 Apr;270(7):1590-7 - PubMed
  14. J Interferon Cytokine Res. 2003 Oct;23(10):553-64 - PubMed
  15. Med Oncol. 1996 Sep;13(3):133-40 - PubMed
  16. Nucleic Acids Res. 2004 Feb 19;32(4):1279-88 - PubMed
  17. Biochem Biophys Res Commun. 1995 Jun 6;211(1):289-95 - PubMed
  18. Am J Transplant. 2009 Feb;9(2):251-7 - PubMed
  19. Immunity. 2008 Aug 15;29(2):295-305 - PubMed
  20. Biochem Biophys Res Commun. 2004 Aug 13;321(1):1-6 - PubMed
  21. Ernst Schering Res Found Workshop. 2006;(56):161-86 - PubMed
  22. Mol Cell Biol. 2001 Feb;21(3):721-30 - PubMed
  23. Immunol Rev. 2002 Oct;188:147-54 - PubMed
  24. J Immunol. 2008 May 1;180(9):5771-7 - PubMed
  25. Genes Dev. 1999 Jan 15;13(2):188-201 - PubMed
  26. J Immunol. 2005 Dec 15;175(12):8260-70 - PubMed
  27. Biochem Soc Trans. 2002 Nov;30(Pt 6):952-8 - PubMed
  28. Cell Immunol. 1994 Dec;159(2):140-51 - PubMed
  29. Mol Cell Biol. 2007 Aug;27(16):5607-18 - PubMed
  30. Nucleic Acids Res. 1999 Sep 15;27(18):3660-6 - PubMed
  31. Mol Cell Biol. 2001 Oct;21(20):6960-71 - PubMed
  32. J Rheumatol. 2004 Jun;31(6):1044-9 - PubMed
  33. EMBO J. 2000 Aug 1;19(15):4154-63 - PubMed
  34. Sci STKE. 2005 Jul 12;2005(292):cm7 - PubMed
  35. J Interferon Cytokine Res. 2008 Nov;28(11):679-91 - PubMed
  36. Pharmacol Ther. 2007 Apr;114(1):56-73 - PubMed
  37. Biochemistry. 2008 Jun 17;47(24):6508-17 - PubMed
  38. Z Gastroenterol. 2006 Jun;44(6):503-11 - PubMed
  39. Cell. 1986 Aug 29;46(5):659-67 - PubMed
  40. Science. 1989 Aug 25;245(4920):852-5 - PubMed
  41. J Biol Chem. 2009 Apr 24;284(17):11216-23 - PubMed
  42. Science. 2007 Jul 20;317(5836):376-81 - PubMed
  43. Mol Cell. 2005 Sep 16;19(6):777-89 - PubMed
  44. J Biol Chem. 1999 Nov 26;274(48):33973-8 - PubMed

Publication Types